Feasibility of Intratumoral Administration With <scp>EPHB4</scp>‐<scp>CAR</scp>‐T Cells for the Treatment of Oral Squamous Cell Carcinoma
Yusuke Ito(National Cancer Center Hospital East), Tetsuya Nakatsura(National Cancer Center Hospital East)
Cited by 2
Related Papers
Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in hepatocellular carcinoma cell lines
|Oncology Reports|2011|32
Identification of Common Cancer Antigens Useful for Specific Immunotherapies to Colorectal Cancer and Liver Metastases
|International Journal of Molecular Sciences|2025|0